AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

Kai-Li Zhang1,2, Qian-Qian Shen1, Yan-Fen Fang1

  • 1Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

Insights

AZD9291, an EGFR inhibitor, disrupts Polycomb repressive complex 2 (PRC2) by inhibiting the EZH2-EED interaction. This epigenetic therapy approach downregulates EZH2 protein and mRNA, showing anti-tumor effects in breast cancer and lymphoma.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Pharmacology

Background:

  • Polycomb repressive complex 2 (PRC2) deregulation drives tumorigenesis.
  • Targeting the EZH2-EED interaction is a key epigenetic cancer therapy strategy.
  • Existing inhibitors for this interaction are limited.

Purpose of the Study:

  • To investigate AZD9291 as a potential disruptor of the EZH2-EED interaction.
  • To evaluate the anti-tumor effects of AZD9291 in breast cancer and lymphoma.
  • To elucidate the regulatory mechanisms of AZD9291 involving EZH2 and miR-34a.

Main Methods:

  • In-cell protein-protein interaction screening using NanoBRET technology.
  • Co-immunoprecipitation (Co-IP), PTSA, and CETSA assays to study PRC2 regulation.
  • MicroRNA array, luciferase reporter assays, and qRT-PCR to analyze molecular interactions.

Main Results:

  • AZD9291, an EGFR inhibitor, disrupts the EZH2-EED interaction, impairing PRC2 activity.
  • AZD9291 treatment leads to EZH2 protein downregulation.
  • AZD9291 upregulates miR-34a, which in turn downregulates EZH2 mRNA expression.

Conclusions:

  • AZD9291 shows potential as a lead compound for developing PRC2 protein-protein interaction antagonists.
  • EZH2 mRNA may be a direct target of miR-34a via non-canonical base pairing.
  • AZD9291 exhibits anti-tumor effects in breast cancer and diffuse large B-cell lymphoma models.

Related Concept Videos

X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
41.7K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.3K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.1K